Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
Nom du journal : Breast Cancer Res Treat
Année : 2015
Volume : 154
Page de départ : 275
Page de fin : 286